OMF | ONEMAIN HLDGS INC

CUSIP: 68268W103

4 Funds Holding

9.3M Total Shares

$631M Total Value

$6.6B

Market Cap

8.6

P/E Ratio

6.3

Forward P/E

$6.56

EPS (TTM)

7.44%

Dividend Yield

$914M

Cash

$22.7B

Total Debt

117M

Shares Out

$38.00

$71.93

52-Week Range

Fund / Manager Click to search	Shares	Value	% of Portfolio	Cost Basis	Est. Return
Brave Warrior Advisors\|Glenn Greenberg	7.7M	$523M	12.25%	$42.07	+55.47%
Patient Capital Management\|Samantha McLemore	824.9K	$56M	2.15%	—	—
Omega Advisors\|Leon Cooperman	700.0K	$47M	1.57%	$48.26	+35.52%
Miller Value Partners\|Bill Miller	82.9K	$6M	1.97%	—	—

Quarter:

Fund / Manager Click to search	Action	Change	Shares After	Value	Price
2025-Q4
Brave Warrior Advisors	SELL	-0.7%	7.7M	$523M	$59.81
Patient Capital Management	SELL	-11.9%	824.9K	$56M	$59.81
Omega Advisors	SELL	-16.6%	700.0K	$47M	$59.81
Miller Value Partners	SELL	-9.8%	82.9K	$6M	$59.81
2025-Q3
Brave Warrior Advisors	SELL	-1.0%	7.8M	$440M	$58.91
Omega Advisors	SELL	-26.3%	839.0K	$47M	$58.91
Patient Capital Management	SELL	-9.3%	936.9K	$53M	$58.91
Miller Value Partners	SELL	-38.3%	91.9K	$5M	$58.91
2025-Q2
Brave Warrior Advisors	BUY	+7.2%	7.9M	$449M	$50.58
Omega Advisors	BUY	+28.1%	1.1M	$65M	$50.58
Patient Capital Management	SELL	-3.7%	1.0M	$59M	$50.58
2025-Q1
Brave Warrior Advisors	SELL	-1.3%	7.3M	$359M	$53.19
Patient Capital Management	SELL	-15.1%	1.1M	$52M	$53.19
Omega Advisors	BUY	+187.7%	889.0K	$43M	$53.19
2024-Q4
Brave Warrior Advisors	BUY	+0.5%	7.4M	$388M	$52.78
Patient Capital Management	SELL	-10.6%	1.3M	$66M	$52.78
Omega Advisors	SELL	-0.1%	309.0K	$16M	$52.78
2024-Q3
Brave Warrior Advisors	BUY	+1.8%	7.4M	$348M	$48.00
Patient Capital Management	SELL	-9.1%	1.4M	$67M	$48.00
Omega Advisors	BUY	+411.5%	309.3K	$15M	$48.00
2024-Q2
Brave Warrior Advisors	BUY	+9.0%	7.3M	$353M	$49.03
Patient Capital Management	SELL	-16.6%	1.6M	$75M	$49.03
Miller Value Partners	SELL	-2.6%	149.0K	$7M	$49.03
Omega Advisors	SELL	-3.8%	60.5K	$3M	$49.03
2024-Q1
Brave Warrior Advisors	BUY	+4.0%	6.7M	$341M	$47.87
Patient Capital Management	SELL	-13.3%	1.9M	$95M	$47.87
Miller Value Partners	SELL	-5.6%	153.0K	$8M	$47.87
2023-Q4
Brave Warrior Advisors	BUY	+21.1%	6.4M	$316M	$38.58
Patient Capital Management	SELL	-0.3%	2.1M	$106M	$38.58
2023-Q3
Brave Warrior Advisors	SELL	-1.0%	5.3M	$212M	$41.51
Patient Capital Management	SELL	-0.7%	2.2M	$86M	$41.51
Omega Advisors	SELL	-81.5%	62.8K	$3M	$41.51
Miller Value Partners	SELL	-10.8%	162.0K	$6M	$41.51
2023-Q2
Brave Warrior Advisors	BUY	+1.1%	5.4M	$234M	$38.33
Patient Capital Management	BUY	+632.9%	2.2M	$95M	$38.33
Miller Value Partners	SELL	-91.3%	181.7K	$8M	$38.33
Omega Advisors	BUY	NEW	340.0K	$10M	$38.33
2023-Q1
Brave Warrior Advisors	SELL	-0.4%	5.3M	$196M	$41.47
Miller Value Partners	SELL	-0.8%	2.1M	$77M	$41.47
Patient Capital Management	BUY	+6.2%	296.1K	$11M	$41.47
2022-Q4
Brave Warrior Advisors	SELL	-1.3%	5.3M	$177M	$36.47
Miller Value Partners	SELL	-1.7%	2.1M	$70M	$36.47
2022-Q3
Brave Warrior Advisors	BUY	+86.2%	5.4M	$159M	$37.55
Miller Value Partners	BUY	+8.4%	2.1M	$63M	$37.55
Patient Capital Management	BUY	+24.3%	278.9K	$8M	$37.55
2022-Q2
Brave Warrior Advisors	BUY	NEW	2.9M	$108M	$43.48
Miller Value Partners	BUY	+17.9%	2.0M	$74M	$43.48
Patient Capital Management	BUY	+42.3%	224.4K	$8M	$43.48
2022-Q1
Miller Value Partners	BUY	+6.2%	1.7M	$79M	$51.29
Patient Capital Management	BUY	+49.6%	157.7K	$7M	$51.29
2021-Q4
Miller Value Partners	SELL	-1.9%	1.6M	$79M	$52.50
2021-Q3
Miller Value Partners	SELL	-26.0%	1.6M	$89M	$57.83
2021-Q2
Miller Value Partners	SELL	-8.3%	2.2M	$130M	$55.96
2021-Q1
Miller Value Partners	SELL	-2.1%	2.4M	$127M	$51.55
2020-Q4
Miller Value Partners	BUY	+0.5%	2.4M	$116M	$38.99
2020-Q3
Miller Value Partners	BUY	+6.7%	2.4M	$75M	$29.42
2020-Q2
Miller Value Partners	BUY	+15.5%	2.3M	$55M	$22.28
2020-Q1
Miller Value Partners	SELL	-19.5%	2.0M	$37M	$41.47
2019-Q4
Miller Value Partners	SELL	-11.2%	2.4M	$102M	$41.65
2019-Q3
Miller Value Partners	SELL	-10.8%	2.7M	$100M	$37.49
2019-Q2
Miller Value Partners	SELL	-3.7%	3.1M	$103M	$32.77
2019-Q1
Miller Value Partners	SELL	-0.3%	3.2M	$101M	$31.44
2018-Q4
Miller Value Partners	BUY	+0.5%	3.2M	$77M	$29.00
2018-Q3
Miller Value Partners	SELL	-5.1%	3.2M	$107M	$34.93
2018-Q2
Miller Value Partners	SELL	-7.5%	3.3M	$111M	$32.93
2018-Q1
Miller Value Partners	SELL	-2.1%	3.6M	$108M	$31.68

6 Months Insider Sentiment

100%

Buy $0 Sell $6.4M

0 Buys

6 Sells

-6.4M Net

4 Grants

Largest

$2.1M Shulman

$1.5M Shulman

$1.4M Shulman

Date	Insider Click to search	Role Click to search	Type	Shares	Price	Value
Jan 14, 2026	Jeannette E Osterhout	EVP & CFO	GRANT	26.4K	—	—
Jan 14, 2026	Micah R. Conrad	EVP & COO	GRANT	31.5K	—	—
Jan 14, 2026	Douglas H. Shulman	President & CEO	GRANT	111.7K	—	—
Jan 02, 2026	Douglas H. Shulman	President & CEO	SELL	15.0K	$68.44	$1.0M
Jan 02, 2026	Douglas H. Shulman	President & CEO	SELL	20.0K	$68.37	$1.4M
Jan 02, 2026	Douglas H. Shulman	President & CEO	SELL	22.5K	$68.44	$1.5M
Nov 26, 2025	Michael A Hedlund	pao, SVP and Group Controller	SELL	652	$62.00	$40K
Nov 07, 2025	Micah R. Conrad	EVP & COO	SELL	5.0K	$59.20	$296K
Nov 03, 2025	Douglas H. Shulman	President & CEO	SELL	35.0K	$59.54	$2.1M
Sep 05, 2025	Douglas H. Shulman	President & CEO	GRANT	8.5K	—	—

OMF | ONEMAIN HLDGS INC

Institutional Ownership of ONEMAIN HLDGS INC

Trading Activity for ONEMAIN HLDGS INC

Insider Trading for ONEMAIN HLDGS INC